Darzalex

Darzalex (daratumumab) is a subcutaneous medication used in the treatment of certain blood cancers. This monoclonal antibody therapy targets specific proteins to help manage conditions like multiple myeloma.

Darzalex is primarily used for the treatment of multiple myeloma, a type of blood cancer. It works by targeting a protein called CD38, which is found on the surface of certain cancer cells. This helps the body's immune system recognize and destroy these cells. Daratumumab is often used in combination with other therapies to manage this condition.

Common effects of Darzalex may include infusion-related reactions, such as fever, chills, and shortness of breath. Other possible effects include fatigue, nausea, and upper respiratory tract infections. These effects can vary from person to person and may not affect everyone who uses this medication.

Darzalex should be administered under the supervision of a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions you have before starting this treatment. Regular monitoring may be required to manage potential side effects and ensure the medication is working effectively.

Darzalex may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect how this medication works, so it is best to follow your healthcare provider's advice on diet and lifestyle during treatment.